Drug-Induced Lupus Erythematosus
Drug-induced lupus erythematosus (DILE) is an autoimmune syndrome whose clinical and laboratory features resemble systemic lupus erythematosus (SLE), but which develops after prolonged exposure to certain medications. The key difference is that DILE symptoms usually improve and disappear once the offending drug is stopped.
At Haute-Derma, dermatology and immunology work closely together on DILE. We aim to recognize the skin signs early and use antibody testing to distinguish it reliably from idiopathic systemic lupus, so we can manage it safely without long-term immunosuppressive drugs.
Types of Drug-Induced Lupus
Our specialists at Haute-Derma classify DILE into three main types based on the pattern of lesions:
- Systemic DILE: Joint pain, fever, and inflammation of the lining of the lungs or heart, but, unlike typical SLE, it rarely affects the kidneys or central nervous system.
- Drug-induced subacute cutaneous lupus (SCLE): Ring-shaped or psoriasis-like scaly lesions on sun-exposed skin (face, neck, arms). This is the form most often seen in dermatology clinics.
- Drug-induced discoid lupus (DLE): Less common; scaly red plaques that can cause scarring and permanent loss of skin pigment.
The Most Common Culprit Drugs
At Haute-Derma, we pay particular attention to medications known to carry a high risk of triggering this reaction:
- High risk: hydralazine (blood pressure) and procainamide (heart rhythm).
- Moderate/low risk: isoniazid (tuberculosis), minocycline (an antibiotic used for acne) and TNF-alpha inhibitors (biologics).
- Drugs that cause SCLE: thiazide diuretics, proton pump inhibitors (PPIs) and the antifungal terbinafine.
Diagnostic Process at Haute-Derma
We use a detailed immunological workup to confirm the diagnosis:
- Medication history: The drug has usually been taken for several months to several years before symptoms appear.
- Specific antibody tests:
- Antihistone antibodies: Positive in more than 90% of patients with systemic DILE.
- Antinuclear antibodies (ANA): Usually positive but not specific.
- Anti-dsDNA: Usually negative, an important clue that separates DILE from SLE.
- Skin biopsy and direct immunofluorescence (DIF): To look for complement and antibody deposits along the dermal–epidermal junction (lupus band test).
- Photosensitivity testing: Assessing how the skin reacts to UV exposure at Haute-Derma.
Specialized Treatment at Haute-Derma
Our treatment plan focuses on removing the cause and controlling symptoms locally:
- Stopping the culprit drug: This is the essential first step. Most symptoms improve within a few weeks of stopping the medication.
- Controlling local inflammation: Topical corticosteroids or calcineurin inhibitors to calm red patches.
- Strict sun protection: Broad-spectrum sunscreen plus oral photoprotection supplements, since UV light makes the skin lesions worse.
- Hydroxychloroquine: May be prescribed short term for persistent skin lesions.
- Regular follow-up: Antibody levels are rechecked after 6–12 months to make sure they have returned to negative.
